, Table of Contents
#
l #
l
Chapter l#1: l#An l#Introduction l#to l#Evidence-Based l#Clinical l#Practice l#Guidelines ........................................ 3
Chapter l#2: l#Pharmacokinetics l#/Chapter3: l#Pharmacodynamics............................................................... 13
Chapter4: l # Pharmacogenetics and l# Pharmacogenomics ........................................................................... 25
e
Chapter l#5: l#Pharmacology l#Across l#the l#Life l#Span .................................................................................. 30
Chapter l#6: l#Drug-Therapy l#Prescribing in l#Special l#Populations .............................................................. 36
e
Chapter l#7: l#Drug l#Development l#and Approval ........................................................................................ 45
e
Chapter l#8-Chapter l#10: l#Foundations l#of l#Prescription l#Writing Chapter l#9: l#ResponsibleControlled-
e
Substance l#Prescribing Chapter l#10: l#Antibiotic l#Stewardship..................................................................... 51
e
Chapter l#11: l#Applied l#Calculations l#for l#Prescribing ............................................................................... 58
Chapter l#12-: l#Promoting Adherence l#With l#Pharmacotherapy l#II: l#System-Specific l#and l#Patient-
e
Focusedl#Prescribing Chapter l#13:l#Pharmacotherapyl#for l#Ear, l#Nose,l#Mouth,l#andThroat l#Conditions l#/Chapter
e
l#14: l#Pharmacotherapy l#for l#Eye l#Conditions............................................................................................. 67
Chapter l#15: l#Pharmacotherapy l#for l#Skin l#Conditions .............................................................................. 74
Chapter l#16: l#Pharmacotherapy l#for l#Neurologic l#Conditions ................................................................... 81
Chapter l# 17: l#Pharmacotherapy l#for l#Cardiovascular l# Conditions ............................................................ 94
Chapter l# 18: l#Pharmacotherapy l#for l#Respiratory l#Conditions................................................................. 106
Chapter l#19: l#Pharmacotherapy l#for l#Gastrointestinal l#Conditions l#and l#Conditions l#RequiringNutritional l#Support
. ........................................................................................................................................................... 117
Chapter l# 20: l#Pharmacotherapy l#for l# Genitourinary l#Conditions ............................................................. 128
Chapter l#21: l#Pharmacotherapy l#for l#Renal, l#Acid–Base, l#Fluid, l#and l#Electrolyte l#Disorders .................... 133
Chapter l# 22: l#Pharmacotherapy l#for l#Musculoskeletal l#and l#Rheumatologic l#Conditions ........................ 146
Chapter l#23: l#Therapeutic l# Applications l# of l#Immunology l#and l#Vaccines .............................................. 158
Chapter l#24: l#Pharmacotherapy l#for l# Endocrine l#Disorders .................................................................... 163
Chapter l#25: l#Pharmacotherapy l#for l#Hematologic l#Disorders ................................................................. 174
Chapter l#26: l#Hematology/Oncology l#and l#Supportive l#Care l#for l#the l#Nononcologist............................... 190
Chapter l # 27: l#Pharmacotherapy l#Related l#to l#Women’s l#Health l#Conditions ........................................... 196
Chapter l#28: l#Pharmacotherapy l#Related l#to l#Men’s l#Health l#Conditions.................................................. 211
Chapter l#29: l#Pharmacotherapy l#Related tol#Transgender l#Care ................................................................. 217
e
Chapter l#30: l#Antimicrobial l#Pharmacotherapy ...................................................................................... 224
Chapter l# 31: l#Antiretroviral l#Pharmacotherapy ...................................................................................... 235
Chapter l#32: l#Psychopharmacology l#and l#Integrative l#Health: l#Combined l#Treatment l#ofPsychiatric
l#and Neurocog l#nitive l#Conditions ........................................................................................................ 247
e e
Chapter l# 33: l#Pharmacotherapy l#for l#Pain l#Management ......................................................................... 257
Chapter l#34: l#Substance l#Use l#Disorder l#III: l#Health l#Promotion l#and l#Maintenance ................................... 267
Chapter l#35: l#Over-the-Counter l# Medications........................................................................................ 283
Chapter l#36: l#Pharmacotherapy l#for l#Obesity ......................................................................................... 291
,Chapterl#1: l#An l#Introduction to l#Evidence-Based l#Clinical l#Practice l#Guidelines
e
MULTIPLE l#CHOICE
• What l#isl#the l#primary l#purpose l#of l#the l#nursing l#assessment?
A. Identifying l#underlying l#pathologic l#conditions
B. Assisting l# the l#physician in identifying l# medical l # conditions
e e
C. Determining l#the l#patients l#mental l#status
D. Exploring l#patient responses l#to l#health l#problems
e
ANS:l#D
A l#nursing l#assessment l#is done l#to identify l#the l#patients response l#to l#health
e e e
l#probl l#ems. l#During the l#nursing
e l#assessment l#phase,
l#a comprehensive information l#bas l#e l#is l#developed l#through l#a l#physical
e e
l#examination, l#nursing l#history, l#medication l#hi l#story, l#and l#professional
l#observation. l#Identifying l#underlying l#pathologic l#condit l#ions l#and l#assisting
l#the physician in l#identifying l#medical l#conditions l#is l#not l#part l#o l#f l#the
e e
l#nursing l#process. l#Determining l#the l#patients l#mental l#status l#is l#one l#part l#of l#th
l#e l#nursing l#assessment, l#but l#it l#is l#not l#the l#primary l#purpose.
e
DIF: l#Cognitive l#Level:
l#Comprehension l # REF: l#dm 36 l#OBJ:
e e
l#1 l#| l#3 l#TOP: l#Nursing l#Pr l#ocess l#Step:
l#Assessment
MSC: l#NCLEX l#Client l#Needs l#Category: l#Health Promotion l#and l#Maintenance
e
• Whatl#isl#the l#basis l#ofl#the NANDAI l#taxonomy?
e
A. Functional l#health l#patterns
B. Human l#response l#patterns
C. Basic l#human needs
e
D. Pathophysiologic l # needs
ANS:l#B
The l#NANDA l#I l # taxonomy l#identifies l#human l#response l#patterns.
e
l#Functional l#components l#of l#health l#patterns l#are l#limited l#to activity, l#fluid
e
l#volume, l#nutrition
, l#self l#care, l#and l#sensory l#perception. l#Basic l#human l#needs l#comprise l#less
l#than l#m l#erely l#health l#patterns. l#Pathophysiologic l#needs l#are l#not l#part of e
l#the scope of l#N l#ANDAl#I.
e e
, DIF: l#Cognitive l#Level: l#Knowledge l#REF:
pp.l#37-38 l#OBJ: l#5 l#TOP:
Nursing l#Process l#Step: l#Diagnosis
MSC: l#NCLEX l#Client l#Needs l#Category: l#Physiological l#Integrity
• Which l#task l#is l#included l#in the l#assessment l#step l#of l#the l#nursing l# process?
e e
A. Establishing l#patient l#goals/outcomes
B. Implementing l#the l#nursing l#care l#plan l#(NCP)
C. Measuring goal/outcome l#achievement
e
D. Collecting l#and l#communicating l#data
ANS: D e
Data l#are l#collected l#and l#communicated l#in the l#assessment l#phase l#of l#the
e
l#nursing l # process. l#Establishing l#goals l#is the l#function of l#planning.
e e e
Implementing the l#NCP l#is l#the l#function l#of l#implementation. l#Measuring
e
l#outcom l#e l#achievement l#is the l#function of l#evaluation.
e e
DIF: l#Cognitive l#Level:
l#Comprehension l#REF: l#dm l#36 l#OBJ: l#2
l#| l#3 l#TOP: l#Nursing l#Pr l#ocess l#Step:
l#Assessment
MSC: l#NCLEX l#Client l#Needs l#Category: l#Health l#Promotion l#and l#Maintenance
e
• Which l#statement l#regarding l#nursing l#diagnoses l# is l# accurate? e
a. Nursing l#diagnoses l#remainl#the l#same l#forl#as l#long as l#the l#disease l#is l#present.
e
b. Nursing l#diagnoses l#are l#written l#to l#identify l#disease l#states.
c. Nursing l#diagnoses l#describe l#patient l#problems that l#nurses l # treat.
e
d. Nursing l#diagnoses l#identify l#causes l#related to illness.
e e e
ANS:l#C
Diagnostic l#statements l#identify l#problems l#a l#nurse is l#independently l#able
e
l#to trea l#t l#within l#the l#scope l#of l#professional l#practice. l#Nursing l#diagnoses
e
l#vary l#with l#the l#c l#hanging l#condition l#of l#the l#patient. l#The l#response l#patterns
l#are l#unique l#to l#the pati e l#ent l#and are l#not disease l#specific.
e e l#Nursing
l#diagnoses l#describe l#the l#patients hum l#an l#response l#pattern.
e
DIF: l#Cognitive l#Level: l#Comprehension
#
l #
l
Chapter l#1: l#An l#Introduction l#to l#Evidence-Based l#Clinical l#Practice l#Guidelines ........................................ 3
Chapter l#2: l#Pharmacokinetics l#/Chapter3: l#Pharmacodynamics............................................................... 13
Chapter4: l # Pharmacogenetics and l# Pharmacogenomics ........................................................................... 25
e
Chapter l#5: l#Pharmacology l#Across l#the l#Life l#Span .................................................................................. 30
Chapter l#6: l#Drug-Therapy l#Prescribing in l#Special l#Populations .............................................................. 36
e
Chapter l#7: l#Drug l#Development l#and Approval ........................................................................................ 45
e
Chapter l#8-Chapter l#10: l#Foundations l#of l#Prescription l#Writing Chapter l#9: l#ResponsibleControlled-
e
Substance l#Prescribing Chapter l#10: l#Antibiotic l#Stewardship..................................................................... 51
e
Chapter l#11: l#Applied l#Calculations l#for l#Prescribing ............................................................................... 58
Chapter l#12-: l#Promoting Adherence l#With l#Pharmacotherapy l#II: l#System-Specific l#and l#Patient-
e
Focusedl#Prescribing Chapter l#13:l#Pharmacotherapyl#for l#Ear, l#Nose,l#Mouth,l#andThroat l#Conditions l#/Chapter
e
l#14: l#Pharmacotherapy l#for l#Eye l#Conditions............................................................................................. 67
Chapter l#15: l#Pharmacotherapy l#for l#Skin l#Conditions .............................................................................. 74
Chapter l#16: l#Pharmacotherapy l#for l#Neurologic l#Conditions ................................................................... 81
Chapter l# 17: l#Pharmacotherapy l#for l#Cardiovascular l# Conditions ............................................................ 94
Chapter l# 18: l#Pharmacotherapy l#for l#Respiratory l#Conditions................................................................. 106
Chapter l#19: l#Pharmacotherapy l#for l#Gastrointestinal l#Conditions l#and l#Conditions l#RequiringNutritional l#Support
. ........................................................................................................................................................... 117
Chapter l# 20: l#Pharmacotherapy l#for l# Genitourinary l#Conditions ............................................................. 128
Chapter l#21: l#Pharmacotherapy l#for l#Renal, l#Acid–Base, l#Fluid, l#and l#Electrolyte l#Disorders .................... 133
Chapter l# 22: l#Pharmacotherapy l#for l#Musculoskeletal l#and l#Rheumatologic l#Conditions ........................ 146
Chapter l#23: l#Therapeutic l# Applications l# of l#Immunology l#and l#Vaccines .............................................. 158
Chapter l#24: l#Pharmacotherapy l#for l# Endocrine l#Disorders .................................................................... 163
Chapter l#25: l#Pharmacotherapy l#for l#Hematologic l#Disorders ................................................................. 174
Chapter l#26: l#Hematology/Oncology l#and l#Supportive l#Care l#for l#the l#Nononcologist............................... 190
Chapter l # 27: l#Pharmacotherapy l#Related l#to l#Women’s l#Health l#Conditions ........................................... 196
Chapter l#28: l#Pharmacotherapy l#Related l#to l#Men’s l#Health l#Conditions.................................................. 211
Chapter l#29: l#Pharmacotherapy l#Related tol#Transgender l#Care ................................................................. 217
e
Chapter l#30: l#Antimicrobial l#Pharmacotherapy ...................................................................................... 224
Chapter l# 31: l#Antiretroviral l#Pharmacotherapy ...................................................................................... 235
Chapter l#32: l#Psychopharmacology l#and l#Integrative l#Health: l#Combined l#Treatment l#ofPsychiatric
l#and Neurocog l#nitive l#Conditions ........................................................................................................ 247
e e
Chapter l# 33: l#Pharmacotherapy l#for l#Pain l#Management ......................................................................... 257
Chapter l#34: l#Substance l#Use l#Disorder l#III: l#Health l#Promotion l#and l#Maintenance ................................... 267
Chapter l#35: l#Over-the-Counter l# Medications........................................................................................ 283
Chapter l#36: l#Pharmacotherapy l#for l#Obesity ......................................................................................... 291
,Chapterl#1: l#An l#Introduction to l#Evidence-Based l#Clinical l#Practice l#Guidelines
e
MULTIPLE l#CHOICE
• What l#isl#the l#primary l#purpose l#of l#the l#nursing l#assessment?
A. Identifying l#underlying l#pathologic l#conditions
B. Assisting l# the l#physician in identifying l# medical l # conditions
e e
C. Determining l#the l#patients l#mental l#status
D. Exploring l#patient responses l#to l#health l#problems
e
ANS:l#D
A l#nursing l#assessment l#is done l#to identify l#the l#patients response l#to l#health
e e e
l#probl l#ems. l#During the l#nursing
e l#assessment l#phase,
l#a comprehensive information l#bas l#e l#is l#developed l#through l#a l#physical
e e
l#examination, l#nursing l#history, l#medication l#hi l#story, l#and l#professional
l#observation. l#Identifying l#underlying l#pathologic l#condit l#ions l#and l#assisting
l#the physician in l#identifying l#medical l#conditions l#is l#not l#part l#o l#f l#the
e e
l#nursing l#process. l#Determining l#the l#patients l#mental l#status l#is l#one l#part l#of l#th
l#e l#nursing l#assessment, l#but l#it l#is l#not l#the l#primary l#purpose.
e
DIF: l#Cognitive l#Level:
l#Comprehension l # REF: l#dm 36 l#OBJ:
e e
l#1 l#| l#3 l#TOP: l#Nursing l#Pr l#ocess l#Step:
l#Assessment
MSC: l#NCLEX l#Client l#Needs l#Category: l#Health Promotion l#and l#Maintenance
e
• Whatl#isl#the l#basis l#ofl#the NANDAI l#taxonomy?
e
A. Functional l#health l#patterns
B. Human l#response l#patterns
C. Basic l#human needs
e
D. Pathophysiologic l # needs
ANS:l#B
The l#NANDA l#I l # taxonomy l#identifies l#human l#response l#patterns.
e
l#Functional l#components l#of l#health l#patterns l#are l#limited l#to activity, l#fluid
e
l#volume, l#nutrition
, l#self l#care, l#and l#sensory l#perception. l#Basic l#human l#needs l#comprise l#less
l#than l#m l#erely l#health l#patterns. l#Pathophysiologic l#needs l#are l#not l#part of e
l#the scope of l#N l#ANDAl#I.
e e
, DIF: l#Cognitive l#Level: l#Knowledge l#REF:
pp.l#37-38 l#OBJ: l#5 l#TOP:
Nursing l#Process l#Step: l#Diagnosis
MSC: l#NCLEX l#Client l#Needs l#Category: l#Physiological l#Integrity
• Which l#task l#is l#included l#in the l#assessment l#step l#of l#the l#nursing l# process?
e e
A. Establishing l#patient l#goals/outcomes
B. Implementing l#the l#nursing l#care l#plan l#(NCP)
C. Measuring goal/outcome l#achievement
e
D. Collecting l#and l#communicating l#data
ANS: D e
Data l#are l#collected l#and l#communicated l#in the l#assessment l#phase l#of l#the
e
l#nursing l # process. l#Establishing l#goals l#is the l#function of l#planning.
e e e
Implementing the l#NCP l#is l#the l#function l#of l#implementation. l#Measuring
e
l#outcom l#e l#achievement l#is the l#function of l#evaluation.
e e
DIF: l#Cognitive l#Level:
l#Comprehension l#REF: l#dm l#36 l#OBJ: l#2
l#| l#3 l#TOP: l#Nursing l#Pr l#ocess l#Step:
l#Assessment
MSC: l#NCLEX l#Client l#Needs l#Category: l#Health l#Promotion l#and l#Maintenance
e
• Which l#statement l#regarding l#nursing l#diagnoses l# is l# accurate? e
a. Nursing l#diagnoses l#remainl#the l#same l#forl#as l#long as l#the l#disease l#is l#present.
e
b. Nursing l#diagnoses l#are l#written l#to l#identify l#disease l#states.
c. Nursing l#diagnoses l#describe l#patient l#problems that l#nurses l # treat.
e
d. Nursing l#diagnoses l#identify l#causes l#related to illness.
e e e
ANS:l#C
Diagnostic l#statements l#identify l#problems l#a l#nurse is l#independently l#able
e
l#to trea l#t l#within l#the l#scope l#of l#professional l#practice. l#Nursing l#diagnoses
e
l#vary l#with l#the l#c l#hanging l#condition l#of l#the l#patient. l#The l#response l#patterns
l#are l#unique l#to l#the pati e l#ent l#and are l#not disease l#specific.
e e l#Nursing
l#diagnoses l#describe l#the l#patients hum l#an l#response l#pattern.
e
DIF: l#Cognitive l#Level: l#Comprehension
